Concord Drugs

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue10.8010.3913.6110.2816.99
Expenses10.2810.3413.4510.0116.69
EBITDA1.391.051.021.100.95
EBIT1.030.670.650.760.64
Profit Before Tax0.530.060.160.270.30
Net Profit0.230.040.120.190.22
Financial Ratios
Operating Profit Margin12.87%10.11%7.49%10.70%5.54%
Net Profit Margin2.13%0.38%0.88%1.85%1.30%
Earning Per Share (Diluted)0.230.040.120.190.16
Dividends Per Share0.000.000.000.000.00